Literature DB >> 18241764

The natural history of autologous fistulas as first-time dialysis access in the KDOQI era.

Andre Biuckians1, Eric C Scott, George H Meier, Jean M Panneton, Marc H Glickman.   

Abstract

BACKGROUND: Patients on hemodialysis depend on durable, easily maintained vascular access. The autologous arteriovenous fistula (AVF) has been the gold standard since the introduction of the Brecia-Cimino fistula in 1966 and is echoed in the current Kidney Disease Outcomes and Quality Initiative (KDOQI) guidelines. The purpose of this study is to determine the natural history of AVF in patients requiring first-time permanent access in a large academic vascular surgery practice.
METHODS: We performed a retrospective review of patients undergoing new access creation from January 1, 2005 to June 30, 2005. The study group consisted of patients with no prior permanent access that underwent AVF creation. Categorical data was compared using chi2 analysis, nominal data was compared using Student t-test, and patency was determined by Kaplan-Meier curves.
RESULTS: During the 6-month period, there were 80 first time AVF creations. The majority of patients were male (69%), African American (55%), and a history of diabetes (55%) and hypertension (96%). Seventy-five percent of patients were already undergoing hemodialysis via catheter access. Seventy-six percent of patients underwent preoperative vein mapping with a mean vein diameter of 3.1 mm. Twenty-six radiocephalic AVF (RCAVF) and 54 brachiocephalic AVF (BCAVF) were created with a mean follow-up of 278 days. At the end of follow-up, 38 (48%) AVF were being used for hemodialysis and only nine (11%) matured without the need for additional intervention. Mean time for AVF maturation was 146 days. Thirty AVF (37%) were abandoned, 16 (20%) of which were primary failures. Mean time to abandonment was 162 days. Twelve (15%) AVF remained patent but were never cannulated. The intervention rate was 1.33 interventions/patient/year and 75% of interventions were percutaneous. Kaplan-Meier analysis determined primary, primary-assisted, and secondary patency was 36% +/- 8.3, 55% +/- 6.5, and 55% +/- 6.5 at 1 year, respectively. Cumulative functional patency was 63% at 1 year.
CONCLUSIONS: In patients receiving a first time permanent access, we found that the majority were AVF and they resulted in low primary patency rates at 1 year and long maturation times. KDOQI encourages AVF creation in order to increase AVF use for dialysis, but the strategy of simply increasing the number being created may not lead to the desired result and potentially lead to an increase in catheter dependence.

Entities:  

Mesh:

Year:  2008        PMID: 18241764     DOI: 10.1016/j.jvs.2007.10.041

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  27 in total

1.  Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation.

Authors:  Eugene S Lee; Qiang Shen; Robert L Pitts; Mingzhang Guo; Mack H Wu; Sarah Y Yuan
Journal:  Vasc Endovascular Surg       Date:  2010-08-18       Impact factor: 1.089

2.  Fistula first: recent progress and ongoing challenges.

Authors:  Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

3.  Choice of vascular access among incident hemodialysis patients: a decision and cost-utility analysis.

Authors:  Hui Xue; Eduardo Lacson; Weiling Wang; Gary C Curhan; Steven M Brunelli
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

4.  Long-Term Outcomes of Arteriovenous Fistulas with Unassisted versus Assisted Maturation: A Retrospective National Hemodialysis Cohort Study.

Authors:  Timmy Lee; Joyce Zhang Qian; Yi Zhang; Mae Thamer; Michael Allon
Journal:  J Am Soc Nephrol       Date:  2019-10-14       Impact factor: 10.121

5.  Innocuous-looking skin scab over an arteriovenous fistula: Case report and literature review.

Authors:  Badri Shrestha; Simon Boyes; Peter Brown
Journal:  World J Nephrol       Date:  2014-08-06

6.  American Society of Nephrology Quiz and Questionnaire 2015: ESRD/RRT.

Authors:  Charmaine E Lok; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

7.  Patients referred for arteriovenous fistula construction: a retrospective outcome analysis.

Authors:  Andrew S Kucey; Doireann P Joyce; Teresa O'Neill; Gregory J Fulton; William D Plant; Brian J Manning
Journal:  Ir J Med Sci       Date:  2019-08-31       Impact factor: 1.568

8.  Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter.

Authors:  Timothy Copeland; Peter Lawrence; Karen Woo
Journal:  J Vasc Surg       Date:  2019-05-27       Impact factor: 4.268

Review 9.  Balloon-assisted maturation (BAM) of the arteriovenous fistula: the good, the bad, and the ugly.

Authors:  Prabir Roy-Chaudhury; Timmy Lee; Ben Woodle; Davinder Wadehra; Begoña Campos-Naciff; Rino Munda
Journal:  Semin Nephrol       Date:  2012-11       Impact factor: 5.299

10.  Role of the VEGF 936 gene polymorphism and VEGF-A levels in the late-term arteriovenous fistula thrombosis in patients undergoing hemodialysis.

Authors:  Ferhan Candan; Gürsel Yildiz; Mansur Kayataş
Journal:  Int Urol Nephrol       Date:  2014-04-20       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.